CORDIS
EU research results

CORDIS

English EN
INNOvative LABS for leveraging cross capacity building between ICT, Health, BIO and Medicine sectors for new emerging industries in personalized health

INNOvative LABS for leveraging cross capacity building between ICT, Health, BIO and Medicine sectors for new emerging industries in personalized health

Objective

The INNOLABS project is cluster/network driven and grounded in the conviction that cluster organizations guarantee a better understanding of what kind of services and added value can be provide to their “clients”. Its specific focus is on unlocking the cross-sectoral collaborative potential of SMEs in combining ICT with the BIO, Health and Medicine sectors representing an emerging but still under-utilised market, and applying such results to personalized ehealth for elderly populations in both rural and urban areas. mHealth is another area within INNOLABS that will help in leveraging outstanding results.

The innovations created by the combination of different value chains get to market fast and need to adapt constantly to changing end-user needs. INNOLABS will study the characteristics in market dynamics and specificities for innovations created by merging ICT and biomedical research. The main outcome of the INNOLABS project will be a catalogue of monetary and non-monetary measures provided by regional innovation clusters to support SMEs to deliver timely and innovative products and services increasing the competitiveness of the SMEs and advances the positioning of European countries in these new emerging markets. Achieving long-term sustainability will be another of INNOLABS targets. All these will be achieved by pursuing the following project objectives:

1) Test and validate optimal support measures sensitive to the specific characteristics of ICT and biomedical markets by comparing measures for traditional value chains with new fast lane measures.

2) Increase the competitiveness of SMEs by using targeted non-monetary support mechanisms that generate added value encompassing expert knowledge, new partnerships and market optimisation of products

3) Secure new funding streams to facilitate sustainable cycles of collaborative IHBM innovation by SMEs on new market platforms.

Coordinator

NORWAY HEALTH TECH

Address

Gaustadalleen 21
0349 Oslo

Norway

Activity type

Higher or Secondary Education Establishments

EU Contribution

€ 3 409 351,77

Participants (8)

Sort alphabetically

Sort by EU Contribution

Expand all

BERLIN PARTNER FUR WIRTSCHAFT UND TECHNOLOGIE GMBH

Germany

EU Contribution

€ 125 944,88

DISTRETTO TECNOLOGICO CAMPANIA BIOSCIENCE SCARL

Italy

EU Contribution

€ 99 647,60

CAP DIGITAL

France

EU Contribution

€ 324 906,25

CLUSTER DE SALUD DE CASTILLA Y LEON

Spain

EU Contribution

€ 182 913,75

EUROB CREATIVE SLNE

Spain

EU Contribution

€ 378 707,88

HEALTH CLUSTERNET

United Kingdom

EU Contribution

€ 124 830

INTERIZON

Poland

EU Contribution

€ 237 906,25

STICHTING HEALTH CLUSTERNET

Netherlands

EU Contribution

€ 81 295

Project information

Grant agreement ID: 691556

Status

Ongoing project

  • Start date

    1 January 2017

  • End date

    31 October 2019

Funded under:

H2020-EU.2.3.2.

  • Overall budget:

    € 5 181 783,20

  • EU contribution

    € 4 965 503,38

Coordinated by:

NORWAY HEALTH TECH

Norway